1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Type 2 Diabetes (T2D) - Pipeline Analysis

Type 2 Diabetes (T2D) - Pipeline Analysis

  • June 2015
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 174 pages

“Type 2 Diabetes (T2D) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of T2D. The report covers all the drugs being developed in various phases (Discovery, Preclinical, Clinical & Marketing). The pipeline focuses on novel pharmacologic drugs & regenerative medicines covering small molecules, monoclonal antibodies, stem cell therapies, Gene therapies, Recombinant proteins and RNA-based therapeutics, but excludes symptom relief drugs, generic combinations. The report also covers some of the hot targets in research for T2D treatments and disease progression biomarkers.

This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Type 2 Diabetes (T2D) Drug market. The report also provide strategic insights on medicines that are likely to have an impact on T2D treatment space and potentially alter standards of care in T2D in the foreseeable future.

Current therapies are focused on the treatment of hyperglycemia than on pancreatic Beta cell dysfunction and they lose efficacy over time as both endogenous insulin secretion and insulin sensitivity decrease. There is a need for type 2 diabetes therapies that act in concert with available agents to provide adequate glycemic control without causing hypoglycemia and weight gain, which are associated with increase in cardiovascular risk. Hence, it provides a tremendous opportunity for upcoming therapies specific to T2D such as MAbs, stem cell-based, gene therapies and RNA-based therapies. These modalities may provide beta-cell protection, regeneration, mass increase with additional benefits of weight loss, triglyceride lowering and kidney protection.

Table Of Contents

Type 2 Diabetes (T2D) - Pipeline Analysis
REPORT DESCRIPTION INTRODUCTION
- Causes and Symptoms
- Diagnosis
- Unmet needs
- Epidemiology
- Current therapies
HOT TARGETS, MECHANISMS and THERAPIES
- Novel Disease mechanisms and therapies
- Leading and hot targets of T2DM
- Novel targets of Diabetes
- T2D disease progression biomarkers
MARKET DATA
- Forecasting model
- Market dynamics
- Market sizing
- Cost burden
PIPELINE ANALYSIS
- Development stage
- Leading players
- Therapeutic segmentation
- Innovative approaches
- Target analysis
Small molecules
- Pipeline
- Competitive landscape Large molecules
- Pipeline
- Competitive landscape MONOCLONAL ABs
- Pipeline
- Competitive landscape STEMCELL THERAPY
- Pipeline
- Competitive landscape RNA BASED THERAPEUTICS
- Pipeline
- Competitive landscape GENETHERAPY
- Pipeline
- Competitive landscape
RECOMBINANT FUSION PROTEINS
- Pipeline
- Competitive landscape
DRUG ANALYSIS BASED ON MECHANISM
MAJOR PLAYERS
- Company Profiles
- Overview, Pipeline and Deals
REFERENCES


Companies Mentioned
ADDEX THERAPEUTICS
AMGEN ASTRAZENECA
BOEHRINGER INGELHEIM
CONNEXIOS LIFE SYSTEMS
ELI and LILLY
EMBER THERAPEUTICS
GLAXOSMITHKLINE
JOHNSON and JOHNSON MERCK and Co MESOBLAST BIOPHARMA LTD POXEL SA TAKEDA PHARMACEUTICALS XOMA CORPORATION

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Diabetic foot ulcers (DFUs)- Market Insights, Epidemiology and Market Forecast-2023

Diabetic foot ulcers (DFUs)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Diabetic foot ulcers (DFUs) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Diabetic foot ulcers (DFUs) - Epidemiology Forecast To 2023

Diabetic foot ulcers (DFUs) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Diabetic foot ulcers (DFUs) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Diabetic foot ulcers (DFUs) in seven major markets (US, France, Germany, ...

Type 2 Diabetes Disease : Patent Overview (Last 5 years)

Type 2 Diabetes Disease : Patent Overview (Last 5 years)

  • $ 2000
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The present disclosure provides therapeutic methods for prevention and treatment of type-2 diabetes comprising administering to the subject an effective amount of FTY720 or an analog.this is claimed in ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.